1. Как не умереть от ишемической болезни сердца

1. Как не умереть от ишемической болезни сердца

^{‹‹1››.} Myerburg RJ, Junttila MJ. 2012. Sudden cardiac death caused by coronary heart disease. Circulation. 28;125(8):1043–52.

^{‹‹2››.} Campbell TC, Parpia B, Chen J. Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China study. Am J Cardiol. 1998;82(10B):18T-21T.

^{‹‹3››.} Shaper AG, Jones KW. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959. Int J Epidemiol. 2012;41(5):1221–5.

^{‹‹4››.} Thomas WA, Davies JN, O’Neal RM, Dimakulangan AA. Incidence of myocardial infarction correlated with venous and pulmonary thrombosis and embolism. A geographic study based on autopsies in Uganda, East Africa and St. Louis, U.S.A. Am J Cardiol. 1960;5:41–7.

^{‹‹5››.} Benfante R. Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: a review. Hum Biol. 1992;64(6):791–805.

^{‹‹6››.} Chen J, Campbell TC, Li J, Peto R. Diet, life-style and mortality in China: A study of the characteristics of 65 Chinese counties. New York: Oxford University Press; 1990.

^{‹‹7››.} Shaper AG, Jones KW. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959. Int J Epidemiol. 2012;41(5):1221–5.

^{‹‹8››.} De Biase SG, Fernandes SF, Gianini RJ, Duarte JL. Vegetarian diet and cholesterol and triglycerides levels. Arq Bras Cardiol. 2007;88(1):35–9.

^{‹‹9››.} Stoy PJ. Dental disease and civilization. Ulster Med J. 1951;20(2):144–58.

^{‹‹10››.} Kris-Etherton PM, Harris WS, Appel LJ, Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23(2): e20–30.

^{‹‹11››.} Shepherd CJ, Jackson AJ. Global fishmeal and fish-oil supply: inputs, outputs and markets. J Fish Biol. 2013;83(4):1046–66.

^{‹‹12››.} Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308(10):1024–33.

^{‹‹13››.} Kwak SM, Myung SK, Lee YJ, Seo HG. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012; 172(9): 686–94.

^{‹‹14››.} Fodor JG, Helis E, Yazdekhasti N, Vohnout B. «Fishing» for the origins of the «Eskimos and heart disease» story: facts or wishful thinking? Can J Cardiol. 2014;30(8):864–8.

^{‹‹15››.} Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2(8666): 757–61.

^{‹‹16››.} Burr ML. Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel. Proc Nutr Soc. 2007;66(1):9–15.

^{‹‹17››.} Burr ML, Ashfi eld-Watt PAL, Dunstan FDJ, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57(2):193–200.

^{‹‹18››.} Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308(10):1024–33.

^{‹‹19››.} Smith DA. ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults. Ann Intern Med. 2012;157(12):JC6–5.

^{‹‹20››.} Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. JAMA. 1953;152(12):1090–3.

^{‹‹21››.} Strong JP. Landmark perspective: Coronary atherosclerosis in soldiers. A clue to the natural history of atherosclerosis in the young. JAMA. 1986;256(20):2863–6.

^{‹‹22››.} Voller RD, Strong WB. Pediatric aspects of atherosclerosis. Am Heart J. 1981;101(6): 815–36.

^{‹‹23››.} Napoli C, D’Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100(11):2680–90.

^{‹‹24››.} Benjamin MM, Roberts WC. Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent). 2013;26(2):124–36.

^{‹‹25››.} McMahan CA, Gidding SS, Malcom GT, et al. Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis. Pediatrics. 2006; 118(4): 1447–55.

^{‹‹26››.} Trumbo PR, Shimakawa T. Tolerable upper intake levels for trans fat, saturated fat, and cholesterol. Nutr Rev. 2011;69(5):270–8.

^{‹‹27››.} Roberts WC. It’s the cholesterol, stupid! Am J Cardiol. 2010;106(9):1364–6.

^{‹‹28››.} O’Keefe JH, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol. 2004;43(11): 2142–6.

^{‹‹29››.} Esselstyn CB. In cholesterol lowering, moderation kills. Cleve Clin J Med. 2000;67(8):560–4.

^{‹‹30››.} Roberts WC. The cause of atherosclerosis. Nutr Clin Pract. 2008;23(5):464–7.

^{‹‹31››.} Roberts WC. The cause of atherosclerosis. Nutr Clin Pract. 2008;23(5):464–7.

^{‹‹32››.} King S. The best selling drugs since 1996 — why AbbVie’s Humira is set to eclipse Pfizer’s Lipitor. http://www.forbes.com/sites/simonking/2013/07/15/the-best-selling-drugs-since-1996-why-abbvies-humira-is-set-to-eclipse-pfi zers-lipitor/. July 15, 2013. Accessed May 1, 2015.

^{‹‹33››.} Ginter E, Kajaba I, Sau?a M. Addition of statins into the public water supply? Risks of side effects and low cholesterol levels. Cas Lek Cesk. 2012;151(5):243–7.

^{‹‹34››.} Ferenczi EA, Asaria P, Hughes AD, Chaturvedi N, Francis DP. Can a statin neutralize the cardiovascular risk of unhealthy dietary choices? Am J Cardiol. 2010;106(4):587–92.

^{‹‹35››.} Draeger A, Monastyrskaya K, Mohaupt M, et al. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol. 2006;210(1):94–102.

^{‹‹36››.} Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in communitydwelling older adults. Q JM. 2009;102(9):625–33.

^{‹‹37››.} Jefferson E. FDA announces safety changes in labeling for some cholesterol-lowering drugs. US Food and Drug Administration website. http://www.fda.gov/NewsEvents/Newsroom/Press_Announcements/ ucm293623.htm. February 28, 2012. Accessed February 14, 2015.

^{‹‹38››.} McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev. 2013;22(9):1529–37.

^{‹‹39››.} Jenkins DJ, Kendall CW, Marchie A, et al. The Garden of Eden — plant-based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century. Comp Biochem Physiol, Part A Mol Integr Physiol. 2003;136(1):141–51.

^{‹‹40››.} Esselstyn CB. Is the present therapy for coronary artery disease the radical mastectomy of the twenty-first century? Am J Cardiol. 2010;106(6):902–4.

^{‹‹41››.} Kadoch MA. The power of nutrition as medicine. Prev Med. 2012;55(1):80.

^{‹‹42››.} Wakai K, Marugame T, Kuriyama S, et al. Decrease in risk of lung cancer death in Japanese men after smoking cessation by age at quitting: pooled analysis of three large-scale cohort studies. Cancer Sci. 2007;98(4):584–9.

^{‹‹43››.} Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol. 1997;79(3):350–4.

^{‹‹44››.} Erridge C. The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4. Br J Nutr. 2011;105(1):15–23.

^{‹‹45››.} Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001–7.

^{‹‹46››.} Ornish D, Scherwitz LW, Doody RS, et al. Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA. 1983;249(1):54–9.

^{‹‹47››.} Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001–7.

^{‹‹48››.} Ellis FR, Sanders TA. Angina and vegan diet. Am Heart J. 1977;93(6):803–5.

^{‹‹49››.} Sweeney M. Effects of very low-fat diets on anginal symptoms. Med Hypotheses. 2004;63(3):553.

^{‹‹50››.} Savarese G, Rosano G, D’amore C, et al. Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis. Int J Cardiol. 2013; 169(4):262–70.

^{‹‹51››.} Colpo E, Vilanova CD, Brenner Reetz LG, et al. A single consumption of high amounts of the Brazil nuts improves lipid profile of healthy volunteers. J Nutr Metab. 2013;2013:1–7.

^{‹‹52››.} Stern RH, Yang BB, Hounslow NJ, et al. Pharmacodynamics and pharmacokineticpharmacodynamic relationships of atorvastatin, an HMG-CoA reductase Inhibitor. J Clin Pharmacol. 2000;40(6):616–3.

^{‹‹53››.} Hegsted M. Dietary Guidelines. Food Politics website. www.foodpolitics.com/wp-content/uploads/ Hegsted.pdf.nd. Accessed February 14, 2015.

^{‹‹54››.} Campbell TC. The Low-Carb Fraud. Dallas, TX: BenBella Books, Inc.; 2014.

^{‹‹55››.} Herman J. Saving U.S. dietary advice from conflicts of interest. Food and Drug Law Journal 2010; 65(20):285–316.

^{‹‹56››.} Herman J. Saving U.S. dietary advice from confl icts of interest. Food and Drug Law Journal 2010; 65(20):285–316.

^{‹‹57››.} Goodwin JS, Goodwin JM. The tomato effect. Rejection of highly efficacious therapies. JAMA. 1984;251(18):2387–90.

^{‹‹58››.} Adams KM, Kohlmeier M, Zeisel SH. Nutrition education in U.S. medical schools: latest update of a national survey. Acad Med. 2010;85(9):1537–42.

^{‹‹59››.} Hearing of California Senate Bill 380. Vimeo website. http://vimeo.com/23744792. April 25, 2011. Accessed February 14, 2015.

^{‹‹60››.} Murray JL. Coke and the AAFP— the real thing or a dangerous liaison? Fam Med. 2010; 42(1):57–8.

^{‹‹61››.} Blum A. AAFP-Coke editorial was music to [our] ears. J Fam Pract. 2010;59(2):74.

^{‹‹62››.} Brownell KD, Warner KE. The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q. 2009;87(1):259–94.

^{‹‹63››.} Brownell KD, Warner KE. The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q. 2009;87(1):259–94.

^{‹‹64››.} Simon, M. AND now a word from our sponsors. Eat Drinks Politics website. http://www.eatdrinkpolitics. com/wp-content/uploads/AND_Corporate_Sponsorship_Report.pdf. January 22, 2013. Accessed February 14, 2015.

^{‹‹65››.} Bruckert E, Pouchain D, Auboiron S, Mulet C. Cross-analysis of dietary prescriptions and adherence in 356 hypercholesterolaemic patients. Arch Cardiovasc Dis. 2012;105(11): 557–65.

^{‹‹66››.} Barnard ND. The physician’s role in nutrition-related disorders: from bystander to leader. Virtual Mentor. 2013;15(4):367–72.